Form 8-K - Current report:
SEC Accession No. 0001730463-24-000104
Filing Date
2024-09-19
Accepted
2024-09-19 08:09:53
Documents
18
Period of Report
2024-09-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K autl-20240913.htm   iXBRL 8-K 34040
2 EX-99.1 autlex-991pr190924.htm EX-99.1 8983
7 autlex-991pr190924001.jpg GRAPHIC 216189
8 autlex-991pr190924002.jpg GRAPHIC 297636
9 autlex-991pr190924003.jpg GRAPHIC 113828
  Complete submission text file 0001730463-24-000104.txt   1075170

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT autl-20240913.xsd EX-101.SCH 2401
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT autl-20240913_def.xml EX-101.DEF 15811
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT autl-20240913_lab.xml EX-101.LAB 26747
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT autl-20240913_pre.xml EX-101.PRE 16484
21 EXTRACTED XBRL INSTANCE DOCUMENT autl-20240913_htm.xml XML 4078
Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38547 | Film No.: 241309132
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)